147 related articles for article (PubMed ID: 28854352)
21. Identification and structural elucidation of four cannabimimetic compounds (RCS-4, AM-2201, JWH-203 and JWH-210) in seized products.
Denooz R; Vanheugen JC; Frederich M; de Tullio P; Charlier C
J Anal Toxicol; 2013 Mar; 37(2):56-63. PubMed ID: 23339188
[TBL] [Abstract][Full Text] [Related]
22. Assessment of types of synthetic cannabinoids in narcotic cases assessed by the Council of Forensic Medicine between 2011-2015, Ankara, Turkey.
Göl E; Çok İ
Forensic Sci Int; 2017 Nov; 280():124-129. PubMed ID: 29028489
[TBL] [Abstract][Full Text] [Related]
23. Validation and application of an UPLC-MS/MS method for the quantification of synthetic cannabinoids in urine samples and analysis of seized materials from the Portuguese market.
Simões SS; Silva I; Ajenjo AC; Dias MJ
Forensic Sci Int; 2014 Oct; 243():117-25. PubMed ID: 25127518
[TBL] [Abstract][Full Text] [Related]
24. Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS.
Gottardo R; Chiarini A; Dal Prà I; Seri C; Rimondo C; Serpelloni G; Armato U; Tagliaro F
J Mass Spectrom; 2012 Jan; 47(1):141-6. PubMed ID: 22282100
[TBL] [Abstract][Full Text] [Related]
25. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry.
Hutter M; Kneisel S; Auwärter V; Neukamm MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():95-101. PubMed ID: 22835826
[TBL] [Abstract][Full Text] [Related]
26. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
[TBL] [Abstract][Full Text] [Related]
27. Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids.
Karinen R; Tuv SS; Øiestad EL; Vindenes V
Forensic Sci Int; 2015 Jan; 246():98-103. PubMed ID: 25485949
[TBL] [Abstract][Full Text] [Related]
28. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
[TBL] [Abstract][Full Text] [Related]
29. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques.
Hutter M; Broecker S; Kneisel S; Auwärter V
J Mass Spectrom; 2012 Jan; 47(1):54-65. PubMed ID: 22282090
[TBL] [Abstract][Full Text] [Related]
30. Identification and quantification of 10 indole/indazole carboxamide synthetic cannabinoids in 36 herbal blends by gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy.
Liu CM; Jia W; Meng X; Hua ZD
J Forensic Sci; 2021 Nov; 66(6):2156-2166. PubMed ID: 34431514
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the pharmacological properties of JWH-122 isomers and THJ-2201, RCS-4 and AB-CHMINACA in HEK293T cells and hippocampal neurons.
Costain WJ; Rasquinha I; Comas T; Hewitt M; Aylsworth A; Rouleau Y; Marleau V; Soo EC; Tauskela JS
Eur J Pharmacol; 2018 Mar; 823():96-104. PubMed ID: 29408093
[TBL] [Abstract][Full Text] [Related]
32. Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice.
Kemp AM; Clark MS; Dobbs T; Galli R; Sherman J; Cox R
Am J Med; 2016 Mar; 129(3):240-4.e1. PubMed ID: 26522795
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous analysis of synthetic cannabinoids in the materials seized during drug trafficking using GC-MS.
Choi H; Heo S; Choe S; Yang W; Park Y; Kim E; Chung H; Lee J
Anal Bioanal Chem; 2013 May; 405(12):3937-44. PubMed ID: 23208283
[TBL] [Abstract][Full Text] [Related]
34. Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopy.
Angerer V; Bisel P; Moosmann B; Westphal F; Auwärter V
Forensic Sci Int; 2016 Sep; 266():e93-e98. PubMed ID: 27297324
[TBL] [Abstract][Full Text] [Related]
35. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE.
Angerer V; Mogler L; Steitz JP; Bisel P; Hess C; Schoeder CT; Müller CE; Huppertz LM; Westphal F; Schäper J; Auwärter V
Drug Test Anal; 2018 Mar; 10(3):597-603. PubMed ID: 28670781
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples.
Dresen S; Kneisel S; Weinmann W; Zimmermann R; Auwärter V
J Mass Spectrom; 2011 Feb; 46(2):163-71. PubMed ID: 21259394
[TBL] [Abstract][Full Text] [Related]
37. High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS.
Yanes EG; Lovett DP
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():42-50. PubMed ID: 23153643
[TBL] [Abstract][Full Text] [Related]
38. Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice.
Bilel S; Tirri M; Arfè R; Ossato A; Trapella C; Serpelloni G; Neri M; Fattore L; Marti M
Neurotoxicology; 2020 Jan; 76():17-32. PubMed ID: 31610187
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of an on-site drug-testing device for the detection of synthetic cannabinoids in illegal herbal products].
Uchiyama N; Kikura-Hanajiri R; Hakamatsuka T
Yakugaku Zasshi; 2015; 135(3):535-41. PubMed ID: 25759062
[TBL] [Abstract][Full Text] [Related]
40. Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project.
Hermanns-Clausen M; Kithinji J; Spehl M; Angerer V; Franz F; Eyer F; Auwärter V
Drug Test Anal; 2016 Oct; 8(10):1030-1038. PubMed ID: 26768345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
